Diamant Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.2M | Sell |
16,705
-3,654,526
| -100% | -$786M | 2.86% | 9 |
|
|
2026
Q1 | $3.67B | Buy |
3,671,231
+3,654,351
| +21,649% | +$811M | 2.67% | 11 |
|
|
2025
Q4 | $3.86M | Sell |
16,880
-500
| -3% | -$114K | 2.79% | 8 |
|
|
2025
Q3 | $4.02M | Sell |
17,380
-1,050
| -6% | -$214K | 2.96% | 8 |
|
|
2025
Q2 | $3.42M | Sell |
18,430
-50
| -0.3% | -$9.29K | 2.61% | 8 |
|
|
2025
Q1 | $3.87M | Hold |
18,480
| – | – | 2.94% | 7 |
|
|
2024
Q4 | $3.28M | Hold |
18,480
| – | – | 2.1% | 11 |
|
|
2024
Q3 | $3.65M | Sell |
18,480
-100
| -0.5% | -$18.7K | 2.29% | 12 |
|
|
2024
Q2 | $3.19M | Hold |
18,580
| – | – | 2.13% | 13 |
|
|
2024
Q1 | $3.38M | Hold |
18,580
| – | – | 2.35% | 12 |
|
|
2023
Q4 | $2.88M | Hold |
18,580
| – | – | 2.13% | 13 |
|
|
2023
Q3 | $2.77M | Sell |
18,580
-900
| -5% | -$132K | 2.28% | 12 |
|
|
2023
Q2 | $2.62M | Hold |
19,480
| – | – | 2.01% | 14 |
|
|
2023
Q1 | $3.1M | Hold |
19,480
| – | – | 2.54% | 10 |
|
|
2022
Q4 | $3.15M | Hold |
19,480
| – | – | 2.83% | 11 |
|
|
2022
Q3 | $2.61M | Hold |
19,480
| – | – | 2.54% | 12 |
|
|
2022
Q2 | $2.98M | Sell |
19,480
-260
| -1% | -$39.7K | 2.69% | 10 |
|
|
2022
Q1 | $3.2M | Sell |
19,740
-350
| -2% | -$50.8K | 2.45% | 9 |
|
|
2021
Q4 | $2.72M | Sell |
20,090
-420
| -2% | -$49.6K | 1.99% | 14 |
|
|
2021
Q3 | $2.21M | Buy |
+20,510
| New | +$2.34M | 1.83% | 16 |
|
|
2021
Q1 | $2.16M | Hold |
19,959
| – | – | 1.9% | 17 |
|
|
2020
Q4 | $2.14M | Buy |
19,959
+11
| +0.1% | +$1.06K | 1.9% | 16 |
|
|
2020
Q3 | $1.75M | Hold |
19,948
| – | – | 1.68% | 19 |
|
|
2020
Q2 | $1.96M | Hold |
19,948
| – | – | 2.06% | 14 |
|
|
2020
Q1 | $1.52M | Sell |
19,948
-2,200
| -10% | -$187K | 1.96% | 16 |
|
|
2019
Q4 | $1.96M | Sell |
22,148
-1,450
| -6% | -$120K | 1.82% | 18 |
|
|
2019
Q3 | $1.79M | Sell |
23,598
-800
| -3% | -$54.8K | 1.79% | 18 |
|
|
2019
Q2 | $1.77M | Hold |
24,398
| – | – | 1.76% | 18 |
|
|
2019
Q1 | $1.97M | Sell |
24,398
-902
| -4% | -$73.8K | 1.98% | 17 |
|
|
2018
Q4 | $2.33M | Sell |
25,300
-750
| -3% | -$66K | 2.62% | 10 |
|
|
2018
Q3 | $2.46M | Sell |
26,050
-3,300
| -11% | -$313K | 2.28% | 12 |
|
|
2018
Q2 | $2.72M | Buy |
29,350
+150
| +0.5% | +$14.6K | 2.63% | 9 |
|
|
2018
Q1 | $2.76M | Sell |
29,200
-800
| -3% | -$87.9K | 2.71% | 10 |
|
|
2017
Q4 | $2.9K | Buy |
+30,000
| New | +$2.83M | 0.42% | 10 |
|
Other funds holding ABBV
Diamant Asset Management's ABBV Position: Q2 2026 in Review
Diamant Asset Management reduced its AbbVie (ABBV) stake by 100% in Q2 2026, selling an estimated $786M and leaving 16,705 shares worth $4.2M. The position accounts for 2.86% of the portfolio, ranked #9.
Diamant Asset Management first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.67B in Q1 2026. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Diamant Asset Management held 16,705 shares of AbbVie worth $4.2M as of Q2 2026.
- Diamant Asset Management sold 3,654,526 AbbVie shares in Q2 2026, an estimated $786M.
- AbbVie made up 2.86% of Diamant Asset Management's portfolio in Q2 2026, its #9 holding.
- Diamant Asset Management first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- Diamant Asset Management's AbbVie position peaked at $3.67B in Q1 2026.
- 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Diamant Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.